These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15711991)

  • 61. Selective peripheral denervation for spasmodic torticollis: 13-year experience with 155 patients.
    Braun V; Richter HP
    J Neurosurg; 2002 Sep; 97(2 Suppl):207-12. PubMed ID: 12296680
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Discussion on The risorius muscle: anatomic considerations with reference to botulinum neurotoxin injection for masseteric hypertrophy.
    Hwang K
    Dermatol Surg; 2014 Dec; 40(12):1340-1. PubMed ID: 25380090
    [No Abstract]   [Full Text] [Related]  

  • 63. Efficacy of botulinum toxin in masseter muscle hypertrophy for lower face contouring.
    Kundu N; Kothari R; Shah N; Sandhu S; Tripathy DM; Galadari H; Gold MH; Goldman MP; Kassir M; Schepler H; Grabbe S; Goldust M
    J Cosmet Dermatol; 2022 May; 21(5):1849-1856. PubMed ID: 35176198
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection.
    No YA; Ahn BH; Kim BJ; Kim MN; Hong CK
    J Cosmet Laser Ther; 2016; 18(2):113-5. PubMed ID: 26073120
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Effects of denervation of the masseter nerve and bite raising on the masseter muscle of developing rats].
    Mineta M
    Gifu Shika Gakkai Zasshi; 1990 Jun; 17(1):32-73. PubMed ID: 2134767
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Botulinum Toxin Injection for Masseteric Hypertrophy Using 6 Point Injection Technique - A Case Report. Proposal of a Clinical Technique to Quantify Prognosis.
    Rathod NN; John RS
    Clin Cosmet Investig Dent; 2023; 15():45-49. PubMed ID: 36974260
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Botox facial slimming/facial sculpting: the role of botulinum toxin-A in the treatment of hypertrophic masseteric muscle and parotid enlargement to narrow the lower facial width.
    Wu WT
    Facial Plast Surg Clin North Am; 2010 Feb; 18(1):133-40. PubMed ID: 20206096
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Botulinum toxin for treatment of masseteric hypertrophy.
    Hui AC
    J Neurol; 2002 Mar; 249(3):345. PubMed ID: 11993538
    [No Abstract]   [Full Text] [Related]  

  • 69. [Botulinum toxin type A treatment of cosmetically disturbing masseteric hypertrophy].
    Rijsdijk BA; van ES RJ; Zonneveld FW; Steenks MH; Koole R
    Ned Tijdschr Geneeskd; 1998 Mar; 142(10):529-32. PubMed ID: 9623101
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [A comparative study of botulinum toxin A and denervation-induced masseter muscle atrophy in rabbits].
    Liu HM; Zhao H
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2380-3. PubMed ID: 20965852
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Unilateral masseter muscle hypertrophy: morphofunctional analysis of the relapse after treatment with botulinum toxin.
    Peretta R; Melison M; Meneghello R; Comelli D; Guarda L; Galzignato PF; Concheri G; Ferronato G
    Cranio; 2009 Jul; 27(3):200-10. PubMed ID: 19697649
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effects of denervation and formoterol administration on facial growth.
    Fitzpatrick B; Woods M; Lynch G; Manton D
    Aust Orthod J; 2014 Nov; 30(2):161-8. PubMed ID: 25549518
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bimaxillary protrusion with masseter muscle hypertrophy treated with titanium screw anchorage and masseter surgical reduction.
    Hashimoto T; Kuroda S; Kamioka H; Mishima K; Sugahara T; Takano-Yamamoto T
    Am J Orthod Dentofacial Orthop; 2009 Apr; 135(4):536-48. PubMed ID: 19361742
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Chronic orofacial pain (OFP) of different origin. A case report].
    Rechenberg DK; Kruse A; Grätz KW; Attin T; Lübbers HT
    Schweiz Monatsschr Zahnmed; 2011; 121(9):839-48. PubMed ID: 21987376
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ultrasound-Guided Botulinum Neurotoxin Injection for Masseter Hypertrophy Based on the Structural Pattern of Deep Inferior Tendon and Masseteric Contraction.
    Wang YH; Chang SL; Hu S; Huang YL
    Plast Reconstr Surg; 2022 Jul; 150(1):240e-242e. PubMed ID: 35767638
    [No Abstract]   [Full Text] [Related]  

  • 76. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.
    Sidebottom AJ; Patel AA; Amin J
    Br J Oral Maxillofac Surg; 2013 Apr; 51(3):199-205. PubMed ID: 22871559
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Magnetic resonance imaging in the diagnosis of asymmetrical bilateral masseteric hypertrophy.
    Fyfe EC; Kabala J; Guest PG
    Dentomaxillofac Radiol; 1999 Jan; 28(1):52-4. PubMed ID: 10202480
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Masseteric hypertrophy associated with administration of anabolic steroids and unilateral mastication: a case report.
    Skoura C; Mourouzis C; Saranteas T; Chatzigianni E; Tesseromatis C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Nov; 92(5):515-8. PubMed ID: 11709687
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Combining ultrasonography and electromyography for botulinum chemodenervation treatment of thoracic outlet syndrome: comparison with fluoroscopy and electromyography guidance.
    Jordan SE; Ahn SS; Gelabert HA
    Pain Physician; 2007 Jul; 10(4):541-6. PubMed ID: 17660852
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Assessment of changes in masseter muscle by three-dimensional close-range photogrammetry after Botulinum toxin type-A injection: A case report with review of literature.
    Bayrak NB; Zeybek M; Sanlioglu I; Dolanmaz D
    J Pak Med Assoc; 2019 Mar; 69(3):418-422. PubMed ID: 30890839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.